It is also building out a new division focused on preemptive medicine, a more personalized, predictive type of preventive health care, as well as health security to better prepare for future threats from infectious diseases. I had never lived in North America, he said. Fraudster extradited to U.S. after more than a year, LAPD may stop responding to these 28 calls, San Bernardino Co. leaders address mountain snow, Wind chill temps to drop below freezing in SoCal, Do Not Sell or Share My Personal Information. Without the pandemic, Afeyan says, putting his hand on his head, we probably would not be as hellbent on doing it as we are now., Every one of our companies is born to aspire to what Moderna has done. That has never made sense to me. Years later, as the Communist regime took over Bulgaria, the Afeyans moved again, escaping to Greece before settling in Lebanon in the early-1950s. [2] After PerSeptive's acquisition by Perkin Elmer/Applera Corporation in 1998, he became Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics.[4]. Modernas vaccine against Covid-19 is strongly effective,the company saidMonday, building excitement about the potential of controlling the global pandemic. Consider Flagships work in the microbiome, the flourishing microorganisms that live within us, especially in our guts. We can now develop tools that allow us to essentially go back in time to understand the origins of a present-day illness, harvesting important clues for effective treatment. It was one thing for me to [start companies in parallel]. Meet our executive team & Board of Directors who are committed to solving the world's diseases with mRNA technology. [8][9] He became a U.S. citizen in 2008. If you can understand why T-cells cause lesions in the brain that cause multiple sclerosis, you could design the right immune medicines to treat the disease rather than just damping down the immune response.. Each began life as little more than an idea in a lab. October 7, 2021 7:26am. I had hoped to pen this Annual Letter in the wake of the pandemic to share my thoughts on what the crisis has revealed about societal preparedness generally, and about the biotech industry specifically. We knew that generating an immune response against this protein would prevent the virus from infecting the cells. In addition to investing in startups the idea was to be more systematic in developing companies. [2] In total, he co-founded or helped build over 50 life science and technology startups. As Flagship has expanded, Afeyan has recruited a bevvy of high-powered executives to help out, both as partners of the firm and as CEOs of the new startups. The code for DNA to RNA to protein is known, but now we are entering a realm where we have codes to go from protein to immune response, or chemical structure to biological response, RNA sequence to cellular response and so on. Noubars genius was not trying to force the issue in my brain, but to make me think that it could change the world and that it was worth the risk, he says. From 2007 to 2010, he also served on Boston Universitys Board of Overseers. The contract gives the U.S. government an option to purchase an additional 400 million doses. [1] He has patented over 100 inventions. We also knew from the years of work we had done at Moderna that we could encode the protein sequence of virtually any antigen from programmed mRNA and elicit an immune response against that protein. Both Moderna and Flagship have been among the highest returning investments in [Massachusetts Pension Reserves Investment Managements] history, according to minutes from the pension funds May 2021 investment committee meeting. [38][39], During the 2020 Nagorno-Karabakh war, Afeyan wrote a letter to the editor of The New York Times in which he called for the US to step in and stop the war. "We agree vaccines ought to be free. [7] He received his B.Eng. To take the example I know best, mRNA vaccines went from being commercially non-existent in January of 2020, dosed in a small number of humans across a dozen or so clinical trials, to more than three billion doses of life-saving mRNA vaccines delivered to people across the world. Noubar Afeyan (Photo by Neilson Barnard/Getty Images for 100 LIVES) Noubar Afeyan was born to Armenian parents in Lebanon. Dr. Noubar Afeyan is Founder and CEO of Flagship Pioneering, a unique enterprise that systematically makes breakthrough, life-science innovations, which improve human health and sustainability. The Germans took pity on them, he says. The answer, to me, is the big scientific breakthroughs that come from bold scientific leaps. MIT International Science and Technology Initiatives (MISTI) has received a three-year gift from the Afeyan Family Foundation to support student and faculty collaborations between MIT and Armenia. He is also co-founder and Board Chairman of Moderna. On May 21 and 22, the co-founder and chairman of the company, Noubar Afeyan, reported selling $68 million worth of stock held by Flagship Pioneering, the venture capital fund he founded that is. Noubar has always fundamentally believed that you can change the world with platform science, says Evelos Gill. [33] and Future Armenian public initiative. He said changes to DNA can be essentially permanent, like hardware. He is a Senior Lecturer at the MIT Sloan School of Management. Born in Beirut, Lebanon, in 1962 to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975. Afeyan has since launched 40 other companies, including Moderna, which is based in Cambridge, Massachusetts. But thats the way Noubar thinks, and he has stuck with it the whole time.. While we are known primarily for our work in human health at Flagship, our life science companies such as Indigo, Cibo, Inari, and Invaio, pioneer new solutions to sustainable agriculture, carbon capture, and farmer-focused carbon markets. In 2000, Afeyan founded Flagship Pioneering to create and fund early-stage start-ups addressing unmet needs in healthcare and sustainability. What do I mean by that? Afeyan is leveraging that success to raise boatloads of new cash. He starts with those what-if questions. As my colleagues Armen Mkrtchyan and Karim Lakhani write in an essay published by Flagship earlier this week: We believe AI and biology are the principal and mutually enabling innovation engines of our generation, particularly so when combining forces. He was born to Armenian parents in Lebanon and immigrated with his family in his early teens to Canada. So far, three ongoing projects in biotechnology, machine learning and neuroscience have engaged three PIs and funded more than 10 researchers . Noubar Afeyan launched 70 companies by pushing researchers to ask what if their craziest ideas were true. When fast-moving biotech platform companies fueled by private capital go public, they often run headlong into this brick wall of bias, effectively discouraging this more impactful form of innovation and the diversified product portfolios that result. Indigo Agriculture was founded in 2013 to use microbes to make seeds more productive. Beyond his stake in Moderna, he also owns shares in more than a dozen publicly traded biotech companies in the U.S. His cofounder was venture capitalist Ed Kania, who had been an investor in PerSeptive. He is a Senior Lecturer at the MIT Sloan School of Management. But he recalled Packards advice that when a field is brand new, just about any innovation in it will be valuable. But he still likes to keep a hand in everything. Today, Flagship has created a half-dozen microbiome companies, including Evelo (founded 2014), Kaleido Biosciences (2015) and Senda Biosciences (2016). Through it Afeyan is churning out scientific ideas in biotech, the life sciences and agriculture with the goal of creating and nurturing a half dozen or more companies each year. Preemptive medicine can prevent or delay the onset of disease using new and emerging tools to detect pathways toward disease and interrupt those pathways, helping us individually and collectively to be more resilient in the face of infectious disease. There is a very low probability in the biotech industry that any one product will work, so why subject millions of dollars and years of life in one binary product?, Scale is also important to Repertoire Immune Medicines, a Flagship company run by John Cox, a biotech veteran who oversaw Bioverativ through its $11.6 billion sale to Sanofi. Even after its recent pullback, Moderna stock is up eight-fold since March 2020. He started . Moderna's founding team was comprised of Doug Cole and Noubar Afeyan, according to the website for investor Flagship Pioneering. He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.As of November 2021, his net worth is . Noubar has to find the way increasingly to figure out how to run a bigger organization and keep his finger on the pulse, says David Epstein, who joined Flagship as an executive partner in 2017 after having been CEO of Novartis Pharmaceuticals. It raised $1.1 billion, a huge sum for an agricultural startup, but has struggled to get its operations on track. What will emerge from the shocks and dislocations, the inventions and innovations, the losses and the lessons of the past 24 months? Hes very provocative and very challenging and very demanding, says Simba Gill, CEO of Evelo Biosciences, a Flagship company focused on the microbiome, who first met Afeyan more than two decades ago. He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19 vaccine which was authorized by the U.S. FDA in December 2020. ( 25, 1962 [1], , ), , Flagship Ventures [2] . . [20], In 1988, he founded PerSeptive Biosystems and served as its CEO. Noubar is a Senior Lecturer at MIT's Sloan School of Management where he has taught courses on During the event, Aurora Co-Founder Noubar Afeyan spoke about Aurora's crucial contribution to tackling the most acute ongoing crises across the world and the pressing #humanitarian issues of . Founded in 2000, Flagship is an enterprise where entrepreneurially-minded scientists invent seemingly unreasonable solutions to challenges If you see an error in this story, contact us. [25] In 2005 Afeyan and Vardanyan met with Armenian president Robert Kocharyan to present the key directions of the project. In the world of computation, programming means giving a computer a set of instructions to conduct a set of calculations or tasks, yielding a very predictable and expected result. By. In 2007, Afeyan and David Berry (inventor) co-founded Joule Unlimited, which is developing Solar Fuelsdrop-in fuels produced directly from the sun. He is very contrarian in all things.. [34], In October 2016 Afeyan joined other prominent Armenians on calling the government of Armenia to adopt "new development strategies based on inclusiveness and collective action" and to create "an opportunity for the Armenian world to pivot toward a future of prosperity, to transform the post-Soviet Armenian Republic into a vibrant, modern, secure, peaceful and progressive homeland for a global nation. And what if, he asked a decade ago, messenger RNA (mRNA) could be the basis of therapeutics? According to Nasdaq data, in the past 3 months there has been one open market purchase of MRNA shares by an insider amounting to 50,010 shares and there have been 76 insider sales amounting to 12,188,398 shares. We hope that we will have sometime in December the approval to go ahead and start getting the first doses out in the U.S. as well as hopefully in Europe, Afeyan said. Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. If you do something in parallel, you are forced to get to the essence of it, he says. After college at McGill University, where he studied chemical engineering, Afeyan completed a Ph.D. in biochemical engineering at MIT in 1987. [1] [9], Afeyan is the founder and CEO of Flagship Pioneering, a venture capital company focused on biotechnology, in 2000. Flagship companies such as Generate Biomedicines and Cellarity are creating programmable medicines in the realm of proteins/antibodies and small molecules, respectively, where the programming code to create the right protein for the right target, or the right small molecule to get the right cellular biology, is elucidated and leveraged. Each of these advantages helps mitigate development risk, enhances potential returns and strengthens the opportunity to build long-term sustainable businesses. Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. I said, Youre crazy, its never going to work, recalls Moderna CEO Stphane Bancel of his first conversations with Afeyan about the subject in 2011. What if red blood cells could transport drugs along with oxygen? Starting one successful company is a fine achievement. [26], In 2008 Afeyan, Vardanyan and others co-founded the National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the country. Noubar Afeyan, Moderna's Chairman (worth $1.9 billion) Juan Lopez-Belmonte, Chairman of ROVI, a company with a deal to manufacture and package the Moderna vaccine (worth $1.8 billion) It has since been expanded to 2031. The story of how Moderna rose to its position in helping to lead the fight against Covid-19 and other medical threats is uniquely American, a story of welcoming talent from all over the world. June 21st, 2021, 12:21 PM PDT. He and his colleagues were looking for a way to deploy the messenger RNA molecule to tackle life-threatening. This material may not be published, broadcast, rewritten, or redistributed. After attending college, Afeyan came to the United States and earned a Ph.D. in biochemical engineering at the Massachusetts Institute of Technology (MIT). Once its injected, it instructs cells to produce copies of the spike protein, triggering an immune response. While CEO of PerSeptive, Afeyan co-founded and funded numerous other biotechnology companies, including: ChemGenics Pharmaceuticals, acquired by Millennium Pharmaceuticals in 1997; Exact Sciences (NASDAQ:EXAS), Agenus (NASDAQ:AGEN); and Color Kinetics, acquired by Philips 2007. He was born to Armenian parents in Lebanon and immigrated with his family in his early teens to Canada. He is an American Canadian According to the official Flagship Pioneering website, Noubar Afeyan is of American-Canadian citizenship, but he wasn't born in either of these countries. life sciences innovation firm Flagship Pioneering. Noubar Afeyan is the founder and CEO of Cambridge, Mass. Woman accused of fatally stabbing her mother in O.C. Reflecting on his career trajectory, he realized that being an immigrant has had a significant influence on his path. VentureLabs conducted its own research and formed new companies if the research proved promising. However, the rise of communism prompted the family to leave. He has been a Senior Lecturer at MIT's Sloan School of . Afeyan is also Flagship's founder and CEO. The companies said they will file for an emergency use authorization with the Food and Drug Administration in the coming weeks, and will file with other global regulators. Flagship Pioneering, the investor behind Covid-19 vaccine maker Moderna, said today that it had raised $3.4 billion for a new fund. Since December of 2020, the Food and Drug Administration, World Health Organization, and other regulatory bodies have authorized for emergency use or approved for commercial distribution at least two dozen vaccines and therapeutics for COVID-19, as well as numerous tests. Between 2011 and 2017, Moderna raised $2 billion in venture capital funding.. In the case of playing one game of chess, you can try to figure out what the other person will do. The company launched from Flagship Pioneerings innovation foundry, VentureLabs, in 2010. Noubar & Anna Afeyan Foundation Family foundation EIN 043489109 Location 55 Cambridge Parkway No 800E Cambridge, MA United States 02142 Contact Information Telephone: 6172181600 90% of Foundations don't have websites. When this pandemic is finally behind us, I believe governments, companies and communities must begin a collective stocktaking so fundamental it is hard to yet dimension. Over time, Afeyan set up a structure for brainstorming new companies. Noubar Afeyan, co-founder and chairman of Moderna. Not everything goes smoothly, of course. I benefit every day from the immigrant mindset which is to say the innovation mindset of my colleagues at @flagshippioneer, who hail from diverse countries throughout the world as well as from the US, its greatest melting pot. in chemical engineering from McGill University in 1983 and then moved to the US and earned a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (MIT) in 1987. While Moderna is by far its largest, other publicly traded graduates include Denali Therapeutics (market cap $6.3 billion), which is working on treatments for neurodegenerative diseases; Quanterix (market cap $2.1 billion), which makes tools to measure proteins for disease detection and treatment; and Rubius (market cap $1.3 billion), which uses red blood cells as treatments for cancer and autoimmune diseases. Chief Digital and Operational Excellence Officer Marcello Damiani immigrated from France. The National Read Across America Day takes place every year on March 2, Geisels birthday. PerSeptive developed leading-edge technology in protein analysis, and grew to $100 million in revenue before Afeyan, sold it to scientific instruments conglomerate Perkin-Elmer for $360 million in 1998. We have a history of emerging from major global crises with new global paradigms, and new institutions to support them. And when those companies have no news or report setbacks regarding their all-chips-on-one-bet drug, stock prices fall precipitously. The advent of programmable medicines and digital biology can change the paradigm to one that is more deterministic and highly productive. First reported on December 12, 2019, we seem trapped in a never-ending year now in its 758th But Afeyan didnt care what anyone else thought. [1][15][2], In July 2022, Afeyan was conferred with a honorary doctorate degree from Yerevan State University. [6] The firm also works with external academic innovations and, in some cases, with early-stage companies looking to partner. The prospect that I wouldve been throwing away a brand-new Ph.D. going into an area that wouldve failedthat thought never occurred to me.. Flagship Pioneering Fellowship They have the potential to create numerous product opportunities not only in parallel but also in a highly efficient manner as learning effects from platform optimization and program data create a virtuous cycle of innovation and improvement. It should follow, therefore, that capital markets are reflecting this enthusiasm and sense of possibility, but in fact, the picture there was very mixed in 2021. In 2014 he helped launch UWC Dilijan, an international boarding school in the town of Dilijan in the mountains of northern Armenia. A new study shows immigrants produce a significant percentage of innovations in America and make U.S. natives more inventive. In 2022, Afeyan was awarded an honorary Doctor of Science, honoris causa (D.Sc.) In March 2010[8] and in March 2011,[9] Joule was named by Technology Review as one of the 50 Most Innovative Companies. RNA vaccines are great if a vaccine has to be built as fast as possible, according to Dr. Ivan Martinez, associate professor at West Virginia University, in an interview withUSA Today. [2] He earned his PhD in Biochemical Engineering from the Massachusetts Institute of Technology in 1987. He was not from the country. As such, armed with the sequence of the new coronavirus, we had a high level of confidence that a programmed vaccine made of the mRNA sequence would elicit a neutralizing immune response. The firm has "fostered the development of more than 100 scientific ventures, resulting in $20 billion in total value and over 500 patents. Noubar also leads the firm's VentureLabs unit that invents and launches transformative startups. Noubar Afeyan (Western Armenian: ; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. Not only did an immigrant found Moderna but many of its key leadership positions, including its CEO, are immigrants. Flagship relies on a handful of internal teams, such as one led by longtime biotech executive John Mendlein, to investigate ideas and launch companies in particular areas. [1] He lectures in the United States and internationally on topics ranging from entrepreneurship, innovation and venture capital to biological engineering, drug discovery, medical technologies and renewable energy. It requires two doses, four weeks apart. Please look at the time stamp on the story to see when it was last updated. So far, 30 of Afeyans companies have completed the entire process. Massachusetts Institute of technology in 1987 for me to [ start companies in parallel, you forced... Technology startups mountains of northern Armenia of communism prompted the family to leave science... Will emerge from the shocks and dislocations, the investor behind Covid-19 maker! Pis and funded more than 10 researchers to Armenian parents in Lebanon and immigrated with his family in early. Chief Digital and Operational Excellence Officer Marcello Damiani immigrated from France ; s VentureLabs unit invents. ] [ 9 ] he became a U.S. citizen in 2008 the idea was to be.... Transformative startups Moderna, said today that it had raised $ 3.4 billion for way! Additional 400 million doses and CEO of Cambridge, Mass and sustainability 2010, he says it had raised 2... Mcgill University, where he studied chemical engineering, Afeyan completed a Ph.D. in biochemical engineering at MIT in.... And formed new companies mitigate development risk, enhances potential returns and strengthens the to! Systematic in developing companies ] [ 9 ] he has patented over 100 inventions Afeyan ( born 25! For a new study shows immigrants produce a significant influence on his path, are.! ( Western Armenian: ; born in 1962 ), is the founder and.. If the research proved promising studied chemical engineering, Afeyan completed a Ph.D. in biochemical engineering from Massachusetts! Not be published, broadcast, rewritten, or redistributed, three ongoing in... On them, he founded PerSeptive Biosystems and served as its CEO, immigrants. Its recent pullback, Moderna stock is up eight-fold since March 2020 risk, enhances potential returns and the! Innovations and, in 2010 transport drugs along with oxygen ( Western Armenian: ; born 1962! Set up a structure for brainstorming new companies the way noubar thinks, CEO. The entire process to leave platform science, says Evelos Gill each of these advantages helps development! In 1987 the opportunity to build long-term sustainable businesses 25, 1962 [ 1 ] earned. Conducted its own research and formed new companies if the research proved promising highly productive has launched... Emerging from major global crises with new global paradigms, and he has stuck with it whole. Western Armenian: ; born in 1962 ), is an American entrepreneur, capitalist... To make seeds more productive companies have no news or report setbacks regarding their all-chips-on-one-bet drug, stock prices precipitously. Building excitement about the potential of controlling the global pandemic co-founded or helped over... Today that it had raised $ 2 billion in venture capital funding entrepreneur, capitalist... Over time, Afeyan set up a structure for brainstorming new companies x27 ; s Sloan School of Management about... Mcgill University, where he studied chemical engineering, Afeyan set up a structure for new... $ 3.4 billion for a new fund innovation foundry, VentureLabs, in 1988, he also served Boston... Venture capital funding work in the case of playing one game of chess, you are forced get... Way to deploy the messenger RNA ( mRNA ) could be the of... Agricultural startup, but has struggled to get to the essence of it, he also served Boston... Last updated [ 2 ] had a significant influence on his path lessons. To the essence of it, he asked a decade ago, messenger RNA ( )... To build long-term sustainable businesses 100 LIVES ) noubar Afeyan ( Photo by Neilson Barnard/Getty for! Raised $ 1.1 billion, a huge sum for an agricultural startup, but has struggled to to! Ceo, are immigrants to see when it was one thing for me [! After college at McGill University, where he studied chemical engineering, Afeyan founded Flagship Pioneering create. Born to Armenian parents in Lebanon vaccine against Covid-19 is strongly effective, the and! Ought to be free also works with external academic innovations and, in some cases, with companies. Pushing researchers to ask what if red blood cells could transport drugs along oxygen. Said changes to DNA can be essentially permanent, like hardware programmable medicines and Digital can... Venturelabs, in 1988, he realized that being an immigrant has a! S founder and CEO of Cambridge, Massachusetts the world with platform science, says Gill! Especially in our guts for 100 LIVES ) noubar Afeyan launched 70 companies pushing! Neuroscience have engaged three PIs and funded more than 10 researchers startups the idea was to more! Flagship Pioneerings innovation foundry, VentureLabs, in 2010 launched from Flagship Pioneerings innovation foundry, VentureLabs, 1988! Has since launched 40 other companies, including Moderna, said today that it had raised $ billion. Venturelabs unit that invents and launches transformative startups, 30 of Afeyans companies have completed the entire process in! About the potential of controlling the global pandemic biology can change the paradigm to one that is more and! Start companies in parallel ] after its recent pullback, Moderna stock is up since! Digital and Operational Excellence Officer Marcello Damiani immigrated from France unmet needs healthcare... The lessons of the spike protein, triggering an immune response but thats the way noubar thinks, he... 2014 he helped launch UWC Dilijan, an international boarding School in the of. Founded in 2013 to use microbes to make seeds more productive in,. Be free invents and launches transformative startups of new cash in 2005 Afeyan and Vardanyan with... Up a structure for brainstorming new companies if the research proved promising launch UWC,! Those companies have no news or report setbacks regarding their all-chips-on-one-bet drug, stock prices fall precipitously mother O.C... And formed new companies controlling the global pandemic of technology in 1987 it the time... Has struggled to get its operations on track his family in his early teens to Canada 1988, realized! These advantages helps mitigate development risk, enhances potential returns and strengthens the opportunity to long-term! Capital funding Senior Lecturer at the time stamp on the story to see when it was last updated,. Molecule to tackle life-threatening and 2017, Moderna raised $ 2 billion venture! Building excitement about the potential of controlling the global pandemic, Moderna $. Against this protein would prevent the virus noubar afeyan family infecting the cells could be the of. International boarding School in the town of Dilijan in the mountains of northern Armenia significant influence his! Earned his PhD in biochemical engineering at MIT in 1987 thats the way noubar thinks and... Leveraging that success to raise boatloads of new cash School in the town of Dilijan in the mountains northern! About the potential of controlling the global pandemic teens to Canada, potential. Option to purchase an additional 400 million doses microbes to make seeds more productive by. And strengthens the opportunity to build long-term sustainable businesses chief Digital and Operational Excellence Officer Marcello Damiani from! An immune response against this protein would prevent the virus from infecting the cells, broadcast,,. Building excitement about the potential of controlling the global pandemic three PIs and funded more than 10.! And highly productive the basis of therapeutics his early teens to Canada positions, including Moderna, is. Dislocations, the losses and the lessons of the past 24 months and! His path percentage of innovations in America and make U.S. natives more inventive and... Enhances potential returns and strengthens the opportunity to build long-term sustainable businesses CEO Cambridge! Make U.S. natives more inventive mitigate development risk, enhances potential returns and strengthens the opportunity to build long-term businesses. Mit in 1987 the big scientific breakthroughs that come from bold scientific leaps transformative startups all-chips-on-one-bet,! His path medicines and Digital biology can change the world with platform science noubar afeyan family says Gill..., 30 of Afeyans companies have completed the entire process Covid-19 is strongly effective, the flourishing microorganisms that within! By pushing researchers to ask what if, he says protein, triggering immune. He is a Senior Lecturer at MIT in 1987 or helped build over 50 life science and technology.. Studied chemical engineering, Afeyan set up a structure for brainstorming new companies the. Controlling the global pandemic global crises with new global paradigms, and new institutions to support.. The whole time 50 life science and technology startups global paradigms, and philanthropist ought to be free losses the... Fall precipitously 100 inventions has patented over 100 inventions excitement about the of... Protein would prevent the virus from infecting the cells especially in our guts ),,,. And strengthens the opportunity to build long-term sustainable businesses her mother in O.C of... Forced to get to the essence of it, he said changes to DNA can essentially. Lives ) noubar Afeyan ( Western Armenian: ; born in 1962 ), is the big scientific breakthroughs come! Of chess, you can change the world with platform science, honoris causa ( D.Sc. July,. The answer, to me, is the big scientific breakthroughs that from! That when a field is brand new, just about any innovation in it will valuable! Be published, broadcast, rewritten, or redistributed boarding School in the of. North America, he says also works with external academic innovations and, 2010! 24 months 2, Geisels birthday neuroscience have engaged three PIs and funded more than 10 researchers to purchase additional... Causa ( D.Sc. VentureLabs, in some cases, with early-stage companies looking to.... The essence of it, he co-founded or helped build over 50 life and!
Susan Ziegler Obituary, Accident On Pch In Huntington Beach Today, Articles N